Funding Details
- Awarder
- Inbox
- Date Award
- May 17, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- Epicrispr Biotechnologies is a biotechnology company focused on developing curative therapies, specifically targeting facioscapulohumeral muscular dystrophy (FSHD), a genetic neuromuscular disease.
- Market
- Curative therapies for genetic neuromuscular diseases
- Location
-
South San Francisco,
California,
USA
- Coinvestors
- Ally Bridge Group, SOLVE FSHD
Links